Abstract
Eymeric Le Reun, Artūrs Meijers, Maria Teresa Romero-Expósito, I.A. Kotov, Daniel Joseph Indelicato
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach
10.1016/j.radonc.2013.05.007 · 2013
Paediatric proton therapy
10.1259/bjr.20190601 · 2020
Comparative effectiveness of proton vs photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer
10.1001/jamaoncol.2019.4889 · 2020
Proton versus photon radiation therapy: a clinical review
10.3389/fonc.2023.1133909 · 2023
Impact of proton versus photon adjuvant radiotherapy on overall survival in the management of skull base and spinal chordomas: a National Cancer Database analysis
2024
Superior intellectual outcomes after proton radiotherapy compared with photon radiotherapy for pediatric medulloblastoma
10.1200/jco.19.01706 · 2020
A systematic review of pediatric neuropsychological outcomes with proton versus photon radiation therapy: a call for equity in access to treatment
10.1017/s1355617722000819 · 2023
Risk of secondary malignant neoplasms in children following proton therapy vs photon therapy for primary CNS tumors: a systematic review and meta-analysis
10.3389/fonc.2022.893855 · 2022
Secondary neutron dose measurement for proton line scanning therapy
2016
Secondary neutrons in clinical proton radiotherapy: a charged issue
10.1016/j.radonc.2007.12.003 · 2008
Secondary neutron dose during proton therapy using spot scanning
10.1016/s0360-3016(01)02826-7 · 2002
Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age
10.1016/j.ijrobp.2008.04.069 · 2008
Proton beam therapy for childhood malignancies: status report
10.1055/s-0030-1249657 · 2010
Pencil beam characteristics of the next-generation proton scanning gantry of PSI: design issues and initial commissioning results
10.1140/epjp/i2011-11066-0 · 2011
Long-term outcomes and quality of life of children with intracranial ependymoma treated with pencil beam scanning proton therapy
10.1002/pbc.31728 · 2025
Evaluation of survival data and two new rank order statistics arising in its consideration
1966
Unresolved referenced work
Kept as external metadata until matched
The effectiveness and safety of proton beam radiation therapy in children and young adults with central nervous system tumors: a systematic review
10.1007/s11060-023-04510-4 · 2024
Pencil beam scanning proton therapy for pediatric intracranial ependymoma
10.1007/s11060-016-2090-4 · 2016
Use of proton therapy for re-irradiation in pediatric intracranial ependymoma
10.1016/j.radonc.2015.07.023 · 2015
Outcomes following proton therapy for pediatric ependymoma
10.1080/0284186x.2017.1413248 · 2018
Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients
10.1093/neuonc/not121 · 2013
Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy
10.1002/cncr.30623 · 2017
Proton therapy for pediatric ependymoma: mature results from a bicentric study
10.1016/j.ijrobp.2021.01.027 · 2021
Incidence of second malignancies among patients treated with proton versus photon radiation
10.1016/j.ijrobp.2013.04.030 · 2013
Photon or proton therapy for adolescent and young adult tumors focused on long-term survivors
2021
Clinical outcomes in a large pediatric cohort of patients with ependymoma treated with proton radiotherapy
10.1093/neuonc/noaa139 · 2021
Studies of the mortality of atomic bomb survivors, report 14, 1950–2003: an overview of cancer and noncancer diseases
10.1667/rr2629.1 · 2012
Solid cancer incidence in atomic bomb survivors: 1958–1998
10.1667/rr0763.1 · 2007
Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950–1997
10.1667/rrav12.1 · 2012
Cancer risk among atomic bomb survivors: the RERF life span study
10.1001/jama.1990.03450050059028 · 1990
Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype
10.1007/s00401-021-02304-4 · 2021
Secondary malignancies following cancer chemotherapy
10.3109/02841869409121767 · 1994
Review of risk factors of secondary cancers among cancer survivors
10.1259/bjr.20180390 · 2019
Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer
10.1016/j.ijrobp.2009.01.040 · 2009
Determining out-of-field doses and second cancer risk from proton therapy in young patients: an overview
10.3389/fonc.2022.892078 · 2022
The ANDANTE project: a multidisciplinary approach to neutron RBE
10.1093/rpd/ncv158 · 2015
Sarcoma arising in irradiated bone: report of 11 cases
10.1002/1097-0142(194805)1:1<3::aid-cncr2820010103>3.0.co;2-7 · 1948
Autonomous DNA nanostructures instructed by hierarchically concatenated chemical reaction networks
10.1038/s41467-021-25450-5 · 2021
Irradiation-induced secondary tumors following pediatric central nervous system tumors: experiences of a single institute in Taiwan (1975–2013)
10.1016/j.ijrobp.2018.04.032 · 2018
No additional external references are available.